Skip to main content
. 1998 May;9(5):1107–1122. doi: 10.1091/mbc.9.5.1107

Table 1.

Oligonucleotides used in constructing lgp120 mutants and chimaeras

Lumenal domain lgp120-5′:
GCAACCGCCGTCCTTCGGCCTCGGC
Lumenal domain lgp120-3′:
GGGGTCGACGCCGATGAGGTAGGCGATGAGGACGAT
Transmembrane domain lgp120-5′:
TTTGTCGACCTGATCCCCATTGCTGTGGGCGGG
Transmembrane domain lgp120-3′:
GGGGTCGACGCCGATGAGGTAGGCGATGAGGACGAT
Cytoplasmic domain lgp120-5′:
TTTGTCGACAGGAAGAGGAGTCACGCGGGCTATCAG
Cytoplasmic domain lgp120-3′:
GCCCTCGAGGCGCACCTGCCCACCAGGCTAGATGGT
lgp120-SDYQRL-3′:
CAGGCTAGAGGCGCTGATAGTCCGAGTGACTCCTC
Lumenal domain TGN38-5′:
AGGGACCAAGCTAGCATGCAGTTCCTGGTTCGGTTGCTC
Lumenal domain TGN38-3′:
GGGGTCGACGTAAGCAATATAGAGGACAGCAACAAG
Transmembrane domain TGN38-5′:
TTTGTCGACTTCTTTGCTTATCTGGTGACCGCT
Transmembrane domain TGN38-3′:
GGGGTCGACGTAAGCAATATAGAGGACAGCAACAAG
Cytosolic domain TGN38-5′:
TTTGTCGACCACAACAAACGAAAGATTATTGCT
Cytosolic domain TGN38-3′:
GCCCTCGAGTCAAAGCTTTAGGTTCAAACGTTGGTA
TGN38-YQTI-3′:
TCAAAGCTTTAGGTTGATAGTTTGGTGTCACT